Driehaus Capital Management LLC
Position in LRMR — Larimar Therapeutics, Inc.
CIK 938206
Chicago, IL
Position in LRMR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,204,795
+$11,164,678 QoQ
Shares Held
2,934,399
+448.0% QoQ
Ownership
2.82%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Driehaus Capital Management LLC holds $3,010,622,183 across 56 Biotechnology names. LRMR ranks #40 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
949,225 | $305,830,802 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
4,491,653 | $261,189,621 | |
| 3 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
6,395,922 | $232,299,887 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
1,920,800 | $161,673,736 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
4,477,942 | $141,055,173 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
2,790,785 | $140,767,195 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
5,911,889 | $111,734,702 | |
| 8 | SEPN |
Septerna, Inc.
|
4,395,572 | $105,625,595 |
All Filings in LRMR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,204,795 | 2,934,399 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,040,117 | 535,464 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,729,548 | 535,464 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,547,490 | 535,464 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $765,389 | 355,995 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,914,342 | 1,269,856 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,378,026 | 1,279,088 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,527,268 | 1,314,106 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $8,259,642 | 1,088,227 | Shares | Sole | 2024-05-15 | |
| 2022-09-30 | $381,513 | 119,223 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $412,580 | 210,500 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $852,525 | 210,500 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,271,295 | 210,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,427,065 | 210,500 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,067,110 | 210,500 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,075,405 | 210,500 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,365,805 | 110,500 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,289,450 | 85,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,092,250 | 85,000 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||